Drug Information
Side Effects > OraVerse

OraVerse Side Effects

Generic Name: phentolamine

Please note - some side effects for OraVerse may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).



OraVerse Side Effects - for the Professional

OraVerse

The most common adverse reaction with OraVerse (incidence ≥ 5% and > control) is injection-site pain. ( 6)



To report SUSPECTED ADVERSE REACTIONS, contact Novalar at 1-888-888-1441 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch


Top

Side Effects by Body System

Cardiovascular

Cardiovascular side effects have included hypotension due to reduced peripheral vascular resistance. This has been a significant cardiovascular complication of phentolamine therapy in some cases. Acute and prolonged hypotensive episodes with reflex tachycardia and cardiac arrhythmias have been reported. Overdosage has been characterized primarily by cardiac arrhythmias, tachycardia and severe hypotension or shock.

If severe hypotension develops, prompt elevation of the patient's legs, infusion of IV fluids and/or volume expanders, and, if necessary, an infusion of norepinephrine (titrated to an acceptable blood pressure) is recommended. Epinephrine should not be used since it may cause a paradoxical reduction in BP.

While limited data have shown that phentolamine can attenuate the marked increases in pulmonary artery pressure and vascular resistance associated with exercise in some patients with primary pulmonary hypertension (PPH), its role in this disease is not clear. A single case of severe, worsened pulmonary hypertension has been reported after the administration of phentolamine to a young woman with PPH. Theoretically, the drug was expected to cause pulmonary arterial vasodilation and an improvement of her condition. Apparently, in patients with PPH, the pulmonary vessels become progressively unresponsive to vasodilator therapy. Phentolamine did induce decreased systemic peripheral vascular resistance in this case, which was associated with increased cardiac output, increased pulmonary blood flow, and, because of a constant pulmonary vascular resistance, increased pulmonary artery blood pressure.

Nervous system

Nervous system side effects have included weakness and dizziness. Anxiety, headache, pupillary contraction and visual disturbances are signs of toxicity.

Respiratory

Respiratory system side effects have included nasal stuffiness, probably due to peripheral vasodilation.

Gastrointestinal

Gastrointestinal side effects have included nausea, vomiting, and diarrhea.

Genitourinary

Genitourinary side effects among male patients who directly inject the penile cavernous body have included prolonged erections/priapism, fibrous plaque formation, severe local pain, cavernositis, urethritis, ecchymosis with hematoma, gross hematuria, and hematospermia. Urinary incompetence has not been reported, although the drug has been used to successfully treat urinary obstruction due to benign prostatic hypertrophy.

Hepatic

Hepatic side effects have included transient hepatic abnormalities, manifested as elevations in liver function tests, with direct injection of phentolamine and papaverine in 0.4% to 40% of men with erectile impotence.

Metabolic

Metabolic side effects have included hypoglycemia. This was probably due to stimulation of insulin as a result of alpha-adrenergic blockade.

Top

More resources:

Drugs.com OraVerse

Micromedex Phentolamine Intracavernosal - Includes detailed dosage instructions.

FDA Phentolamine

Facts & Comparisons Phentolamine

FDA OraVerse

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


MedNotes
Advertisement

(web4)